The local infusion of CAR‐T cells to tumour sites81Modulation of chemokine signalling: overexpressing CCR4,CCR2b or CXCR3 ligands on CSCs‐targeted CAR‐T cells82, 83, 84First using traditional therapies to remove most of the tumour cells, and then applying CAR‐T therapy to target CSCs85. This evidence concerns the gene CCR2 and neoplasm.